Our Blog

Integumen PLC – Highlands Nat. Resources agreement with Cellulac

Integumen is pleased to note Highlands Natural Resources plc’s (“Highlands”) announcement that it has entered into a two-year agreement to provide hemp-derived CBD grown under quality-controlled conditions, with less than 0.2% THC, to Cellulac plc (9.35% owned by Integumen plc) for conversion to medical grade CBD. This will then be incorporated into, and tested on, Integumen plc’s CBD infused wound care “Wound pHase” and STOER range of skincare products.

Read More

Plant Health Care PLC – New Distribution Agreement with Wilbur-Ellis

Plant Health Care®, a leading provider of novel patent-protected biological products to global agriculture markets, announces a new distribution agreement with Wilbur-Ellis Company LLC, a leading U.S. agriculture distributor, for exclusive access to Employ®, a commercial brand for Harpin αß, for use in U.S. specialty crop markets.

Read More

OptiBiotix Health PLC – Distribution Agreement for SlimBiome® in Thailand

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, announces it has entered into a three year distribution agreement with Primo Trading Co., Ltd (“Primo”) to exclusively distribute and commercialise OptiBiotix’s SlimBiome® and SlimBiome® containing ingredients in Thailand.

Read More

Oncimmune Holdings PLC – Agreement for Portugal and Spain

Oncimmune Holdings plc (AIM: ONC.L), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, today announces that it has signed an exclusive agreement for the distribution of its EarlyCDT-Lung test kit in Portugal with Sabartech S.L., its existing distributor in Spain.The agreement includes a minimum sales commitment of £700,000 over 5 years. 

Read More

RISK WARNING